ZBH
ZIMMER BIOMET HOLDINGS, INC.
NYSE · Healthcare · Medical - Devices · US
$95.36
+1.18%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $1.89
- Revenue estimate
- $2.0B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $2.07
- EPS estimate
- $2.01
- Revenue actual
- $2.2B
- Revenue estimate
- $2.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +5.4%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $103
- PT range
- $93 – $110
- Analysts
- 7
3 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $2.01 | $2.07 | Beat 2.99% | $2.2B |
| Apr 28, 2026 | $1.86 | $2.09 | Beat 12.37% | $2.1B |
| Nov 5, 2025 | $1.87 | $1.90 | Beat 1.60% | $2.0B |
| Aug 7, 2025 | $1.98 | $2.07 | Beat 4.55% | $2.1B |
| Feb 6, 2025 | $2.30 | $2.31 | Beat 0.43% | $2.0B |
| May 2, 2024 | $1.87 | $1.94 | Beat 3.74% | $1.9B |
| Feb 8, 2024 | $2.15 | $2.20 | Beat 2.33% | $1.9B |
| Aug 1, 2023 | $1.82 | $1.82 | Beat 0.05% | $1.9B |
| May 2, 2023 | $1.66 | $1.89 | Beat 14.06% | $1.8B |
| Feb 3, 2023 | $1.83 | $1.88 | Beat 2.79% | $1.8B |
| Nov 2, 2022 | $1.56 | $1.58 | Beat 1.09% | $1.7B |
| Aug 2, 2022 | $1.65 | $1.82 | Beat 10.57% | $1.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026